Microelectrode Array (MEA)

MEA-Chantes 320MEA-FAP 320Cardiomyocytes on MEA 320

Recordings of extracellular potentials from microelectrode arrays (MEA) offers non-invasive and long-term monitoring of monolayers of spontaneously contracting cardiomyocytes. Simultaneous current clamp and MEA recording from the same cardiomyocyte culture demonstrate comparable components of the waveforms in both assay systems, as well as similar modulation of the analyzed parameters by cardioactive drugs.

Spontaneously-beating Cor.4U® human cardiomyocytes have electrophysiological properties typical for primary cardiac myocytes, e.g. voltage-gated ion currents, or ß-adrenergic and muscarinic receptors.

The combination of the MEA technology with Cor.4U® human iPS cell-derived cardiomyocytes provides an ideal non-invasive and label-free tool to assess the pharmacology and safety of drug candidates.

Unique features:

  • Non-invasive, long-term monitoring of cardiomyocytes.
  • Primary-like human cardiomyocyte phenotype in a highly standardized, convenient cell model .
  • Assessment of both direct and indirect effects on cardiac electrophysiology

To perform experiments with Cor.4U@ human cardiomyocytes using the MEA technology has been optimised for the Axion Maestro (http://www.axionbiosystems.com/products/mea-systems) and the Multi Channel Systems MEA instruments (http://www.multichannelsystems.com).

MEA Assay Services are offered by Axiogenesis, and by collaboration partners. This email address is being protected from spambots. You need JavaScript enabled to view it.


Nattermannallee 1, Bldg S20
50829 Cologne
Germany –  (Map)

600 W Germantown Pike, Suite 110
Plymouth Meeting, PA 19462
USA – (Map)


Orders: order@axiogenesis.com
Support: support@axiogenesis.com
Other: office@axiogenesis.com


Twitter:  |   LinkedIn:  |   Newsletter:  Subscribe Axiogenesis Newsletter


Phone (Main)
+49 221 99 88 18-0

Phone (US)
+1 844-511-6959

Fax + 49 221 99 88 18-10